Best Stocks Under $20.00 for 2021

The stock market has had an incredible bull-run since the Great Recession of 2008 and 2009. Stocks continue to hit new all-time highs and the price-to-earnings ratios of most S&P 500 companies look very expensive. Many investors are having trouble finding low-priced stocks that haven't already appreciated greatly during the last decade. It's hard to find a good deal on Wall Street right now when even small S&P 500 companies are trading at market caps above $1 billion.

Stocks have gotten expensive both in-terms of share price and their valuation relative to earnings. In more normal markets, a typical S&P 500 company has traded at about fifteen times their earnings. Most stocks are currently trading closer to 25 times their annual earnings. While the stock market has become more expensive as a whole, there are still a handful of undervalued stocks that are trading at less than $20.00 per share.

Value investing opportunities do exist if you're looking in the right places. Putting together a list of the best stocks under $20.00 requires investors to look at smaller and riskier companies and in sectors that are either undiscovered or unloved by the market as a whole. Some of these cheap stocks may not look especially attractive today, but long-term investors will profit if they are willing to exercise patience and hold on to shares of these comapnies through multiple economic cycles.

Some of these companies are solid investing ideas because they are too little and considered too risky to attract the interest of most managed mutual funds and Wall Street money managers. Others operate in unloved and untested areas of the market. You may find even find crypto stocks, marijuana stocks and bitcoin stocks on this list. Others have been beat up by Mr. Market after a long period of slowing profits, but are now actively trying to turn around their business and bounce back. These low-priced stocks operate in a lot of different industries, but these picks all carry two common characteristics. They all have a super-low share price of $20.00 or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.


Ocular Therapeutix logo

#1 - Ocular Therapeutix

NASDAQ:OCUL
Stock Price: $10.85 (+$0.27)
PE Ratio: -5.68
Market Cap: $830.93 million
Average Trading Volume: 940,171 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $26.00 (139.6% Upside)
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Omeros logo

#2 - Omeros

NASDAQ:OMER
Stock Price: $15.95 (+$0.11)
PE Ratio: -6.97
Market Cap: $996.81 million
Average Trading Volume: 586,539 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $40.60 (154.5% Upside)
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
Héroux-Devtek logo

#3 - Héroux-Devtek

OTCMKTS:HERXF
Stock Price: $15.00
Average Trading Volume: 839 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $21.25 (41.7% Upside)
Héroux-Devtek Inc. engages in the design, development, manufacture, assembling, and repair and overhaul of aircraft landing gears, hydraulic and electromechanical flight control actuators, custom ball screws, and fracture-critical components. The company is also involved in the surface treatment of landing gear components; assembling and installation of aircraft components at customer assembly lines, as well as offers electronic enclosures, heat exchangers, cabinets, and titanium components. It serves commercial and defense sectors of the aerospace industries. It operates in Canada, the United States, the United Kingdom, Rest of Europe, Spain, and internationally. The company was formerly known as Heroux Inc. and changed its name to Héroux-Devtek Inc. in 2000. Héroux-Devtek Inc. was incorporated in 1942 and is headquartered in Longueuil, Canada.
CES Energy Solutions logo

#4 - CES Energy Solutions

OTCMKTS:CESDF
Stock Price: $1.20 (+$0.03)
Average Trading Volume: 29,550 shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.88 (139.6% Upside)
CES Energy Solutions Corp., together with its subsidiaries, provides consumable chemical solutions throughout the life-cycle of the oilfield. It provides solutions at the drill-bit, at the point of completion and stimulation, at the wellhead and pump-jack, and through to the pipeline and midstream market. The company's solutions include corrosion inhibitors, demulsifiers, H2S scavengers, paraffin control products, surfactants, scale inhibitors, biocides, and other specialty products. It also designs and implements drilling fluid systems and completion solutions for oil and gas producers; and designs and manufactures production and specialty chemicals for use in the oil and natural gas production markets, the stimulation and fracturing markets, and the pipeline and midstream markets. In addition, the company provides environmental consulting, water management services, and drilling fluids waste disposal services primarily to oil and gas producers; and operates trucks and trailers to transport products in the oil and gas industry. It serves oil and natural gas industry, including multinational producers, intermediate oil and natural gas operators, independent juniors, and joint ventures, as well as pipeline and mid-stream markets in western Canada and the United States. The company was formerly known as Canadian Energy Services & Technology Corp. and changed its name to CES Energy Solutions Corp. in June 2017. CES Energy Solutions Corp. was incorporated in 1986 and is headquartered in Calgary, Canada.
Redwood Trust logo

#5 - Redwood Trust

NYSE:RWT
Stock Price: $12.74 (+$0.07)
PE Ratio: 4.52
Market Cap: $1.44 billion
Average Trading Volume: 1.11 million shares
P/E Ratio: 4.5
Dividend Yield: 5.68 %
Consensus Rating: Buy (7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $13.21 (3.7% Upside)
Redwood Trust, Inc. is a financial company, which focuses on several distinct areas of housing credit. It operates through the segments: Residential Lending, Business Purpose Lending, Third-Party Investments, and Corporate. The Residential Lending segment consists of a mortgage loan conduit that acquires residential loans from third-party originators for subsequent sale, securitization, or transfer into the investment portfolio. The Business Purpose Lending segment includes the platform that originates and acquires business purpose residential loans. The Third-Party Investments segment consists of investments in residential mortgage-backed securities (RMBS) issued by third parties, investments in Freddie Mac K-Series multifamily loan securitizations and SLST reperforming loan securitizations. The company was founded by George E. Bull III, Douglas B. Hansen and Frederick H. Borden on April 11, 1994 and is headquartered in Mill Valley, CA.
Northern Oil and Gas logo

#6 - Northern Oil and Gas

NYSEAMERICAN:NOG
Stock Price: $18.69 (+$0.89)
PE Ratio: -1.57
Market Cap: $1.24 billion
Average Trading Volume: 1.04 million shares
Dividend Yield: 0.67 %
Consensus Rating: Buy (8 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $20.43 (9.3% Upside)
Northern Oil & Gas, Inc. engages in the acquisition, exploration, development, and production of crude oil and natural gas properties. It focuses on the Bakken and Three Forks formation within the Williston Basin in North Dakota and Montana. The company was founded on March 20, 2007 and is headquartered in Minnetonka, MN.
Xponential Fitness logo

#7 - Xponential Fitness

NYSE:XPOF
Stock Price: $11.54 (+$0.38)
Market Cap: $537.04 million
Average Trading Volume: 188,973 shares
Consensus Rating: Buy (8 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $16.79 (45.5% Upside)
Xponential Fitness Inc. is a curator of boutique fitness brands across multiple verticals. The company built and curated a diversified platform of boutique fitness brands spanning across verticals including Pilates, indoor cycling, barre, stretching, rowing, dancing, boxing, running and yoga. Its portfolio of brands includes Club Pilates, CycleBar, StretchLab, Row House, AKT, YogaSix and STRIDE. Xponential Fitness Inc. is headquartered in Irvine, California.
CymaBay Therapeutics logo

#8 - CymaBay Therapeutics

NASDAQ:CBAY
Stock Price: $3.89 (+$0.09)
PE Ratio: -3.93
Market Cap: $268.40 million
Average Trading Volume: 816,251 shares
Consensus Rating: Buy (8 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $10.13 (160.3% Upside)
CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products pipeline include Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.
Secure Energy Services logo

#9 - Secure Energy Services

OTCMKTS:SECYF
Stock Price: $3.40 (+$0.09)
Average Trading Volume: 5,625 shares
Consensus Rating: Buy (9 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $6.56 (93.0% Upside)
Secure Energy Services, Inc. engages in the provision of safe and environmentally responsible fluids and solids solutions to the oil and gas industry. It operates through the following segments: Midstream Infrastructure, Environmental and Fluid Management, and Corporate. The Midstream Infrastructure segment operates facilities throughout western Canada, in North Dakota and in Oklahoma and helps upstream oil and natural gas companies with the processing, storing, shipping and marketing of crude oil; processing of waste; and water treatment and disposal. The Environmental and Fluid Management segment focuses on landfill disposal facilities; onsite abandonment, remediation and reclamation management; and drilling, completion and production fluid operations management for oil and gas producers in western Canada. The company was founded in 2007 and is headquartered in Calgary, Canada.
Vodafone Group logo

#10 - Vodafone Group

NASDAQ:VOD
Stock Price: $16.00 (+$0.05)
PE Ratio: 17.02
Market Cap: $44.27 billion
Average Trading Volume: 3.65 million shares
P/E Ratio: 17.0
Dividend Yield: 6.52 %
Consensus Rating: Buy (12 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $16.67 (4.2% Upside)
Vodafone Group Plc engages in telecommunication services in Europe and internationally. The firms offers mobile services that enable customers to call, text and access data, fixed line services, including broadband, television (TV) offerings, and voice and convergence services under the GigaKombi and Vodafone One names to customers. It also provides mobile, fixed and a suite of converged communication services, such as Internet of Things (IoT) comprising managed IoT connectivity, automotive and insurance services, as well as smart metering and health solutions, cloud and security portfolio comprising public and private cloud services, as well as cloud-based applications and products for securing networks and devices and international voice, IP transit and messaging services to support business customers that include small home offices and large multi-national companies. The company was founded on July 17, 1984 and is headquartered in Newbury, the United Kingdom.
Energy Transfer logo

#11 - Energy Transfer

NYSE:ET
Stock Price: $9.49 (+$0.24)
PE Ratio: 7.24
Market Cap: $25.67 billion
Average Trading Volume: 17.84 million shares
P/E Ratio: 7.2
Dividend Yield: 6.59 %
Consensus Rating: Buy (13 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $12.91 (36.0% Upside)
Energy Transfer LP provides natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities and gathering systems and deliver the natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acqui
Nuvation Bio logo

#12 - Nuvation Bio

NYSE:NUVB
Stock Price: $9.50 (-$0.29)
PE Ratio: -41.30
Market Cap: $2.07 billion
Average Trading Volume: 759,599 shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $17.40 (83.2% Upside)
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting CDK2, CDK4, and CDK6. It is also developing NUV-868, a selective inhibitor of the BET family of epigenetic transcriptional regulators; NUV-569, a differentiated selective inhibitor of the Wee1 kinase; NUV-1182, an adenosine receptor inhibitor; and DDC platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to androgen receptor-expressing cancer cells , as well as PARP inhibitor to ER-expressing cancer cells. The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was incorporated in 2018 and is headquartered in New York, New York.
Enerplus logo

#13 - Enerplus

NYSE:ERF
Stock Price: $6.85 (+$0.36)
PE Ratio: -5.57
Market Cap: $1.76 billion
Average Trading Volume: 1.89 million shares
Dividend Yield: 1.85 %
Consensus Rating: Buy (9 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $10.69 (56.0% Upside)
Enerplus Corp. engages in the exploration and production of crude oil and natural gas. It conducts operations in Willston Basin, Marcellus Shale, and Canadian Waterfloods. The company was founded in 1986 and is headquartered in Calgary, Canada.
Digital Media Solutions logo

#14 - Digital Media Solutions

NYSE:DMS
Stock Price: $7.34 (-$0.10)
PE Ratio: 146.80
Market Cap: $456.31 million
Average Trading Volume: 110,502 shares
P/E Ratio: 146.8
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $15.00 (104.4% Upside)
Digital Media Solutions, Inc. is a marketing technology company, which engages in the provision of performance-driven brand and marketplace solutions to connect, consumers and advertisers. It operates through the following segments: Brand Direct, Marketplace, and Other. The Brand Direct segment comprises fees from the charge collected to customer when the company advertise directly for them under their brand name. The Marketplace segment include fees charge to customer from advertising their business under company's brand name. The Other segment provides management of digital media services on behalf of customers as well as SaaS. The company was founded by Joseph L. Marinucci, Fernando Borghese, Luis A. Ruelas, Matt Goodman, and David Shteif in 2012 and is headquartered in Clearwater, FL.
SeaSpine logo

#15 - SeaSpine

NASDAQ:SPNE
Stock Price: $16.23 (+$0.48)
PE Ratio: -13.20
Market Cap: $590.74 million
Average Trading Volume: 156,448 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $25.20 (55.3% Upside)
SeaSpine Holdings Corp. operates as a medical technology company. The firm engages in the design, developmen and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It products include thoracolumbar hardware, cervical hardware, orthobiologics, and spine pure strip. The company was founded on February 12, 2015 and is headquartered in Carlsbad, CA.
Dyne Therapeutics logo

#16 - Dyne Therapeutics

NASDAQ:DYN
Stock Price: $17.05 (+$0.93)
PE Ratio: -4.57
Market Cap: $874.29 million
Average Trading Volume: 317,816 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $34.25 (100.9% Upside)
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was founded in 2017 and is headquartered in Waltham, Massachusetts.
PDS Biotechnology logo

#17 - PDS Biotechnology

NASDAQ:PDSB
Stock Price: $17.08 (+$1.09)
PE Ratio: -30.50
Market Cap: $485.48 million
Average Trading Volume: 1.35 million shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $16.77 (-1.8% Upside)
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.
NeuroPace logo

#18 - NeuroPace

NASDAQ:NPCE
Stock Price: $17.09 (-$0.14)
Market Cap: $415.22 million
Average Trading Volume: 104,938 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $26.80 (56.8% Upside)
NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Coherus BioSciences logo

#19 - Coherus BioSciences

NASDAQ:CHRS
Stock Price: $17.52 (+$0.46)
PE Ratio: -7.55
Market Cap: $1.34 billion
Average Trading Volume: 973,575 shares
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $27.80 (58.7% Upside)
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.
Fidus Investment logo

#20 - Fidus Investment

NASDAQ:FDUS
Stock Price: $17.64 (+$0.07)
PE Ratio: 4.93
Market Cap: $431.07 million
Average Trading Volume: 122,680 shares
P/E Ratio: 4.9
Dividend Yield: 7.29 %
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $18.00 (2.0% Upside)
Fidus Investment Corporation is a business development company specializing in leveraged buyouts, refinancings, change of ownership transactions, recapitalizations, strategic acquisitions, mezzanine, growth capital, business expansion, lower middle market investments, debt investments, subordinated and second lien loans, senior secured and unitranche debt, preferred equity, warrants, subordinated debt, senior subordinated notes, junior secured loans, and unitranche loans. It does not invest in turnarounds or distressed situations. The fund prefers to invest in aerospace and defense, business services, consumer products and services including retail, food, and beverage, healthcare products and services, industrial products and services, information technology services, niche manufacturing, transportation and logistics, and value-added distribution sectors. It seeks to invest in companies based in United States. The fund typically invests between $5 million and $15 million per transaction in companies with annual revenues between $10 million and $150 million and an annual EBITDA between $3 million and $20 million, but it can occasionally invest in larger or smaller companies. It seek

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.